Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma

Journal of Neuropathology and Experimental Neurology

Volumn 68, Issue 5, 2009, Pages 542-551

  Hegedus, Balazs ^a   Hughes, Frank W ^c,d   Garbow, Joel R ^b   Gianino, Scott ^a   Banerjee, Debasish ^b   Kim, Keunyoung ^d   Ellisman, Mark H ^d   Brantley Jr , Milam A ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Radiology ^*

^c RUSH UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Magnetic resonance imaging; Neurofibromatosis 1; Optic pathway glioma; Retinal ganglion cell; Visualevoked potential

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; ENOLASE; GREEN FLUORESCENT PROTEIN;

AMPLITUDE MODULATION; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISORIENTATION; EVOKED VISUAL RESPONSE; GENETICS; MOUSE; NERVE CELL; NERVE FIBER; NEUROFIBROMATOSIS; NONHUMAN; OPTIC NERVE; OPTIC NERVE DISEASE; OPTIC NERVE GLIOMA; OPTIC NERVE LESION; PRIORITY JOURNAL; RETINA GANGLION CELL; TUMOR LOCALIZATION; VISION; VISUAL IMPAIRMENT; AGE; ANIMAL; ANISOTROPY; C57BL MOUSE; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE MODEL; ELECTRORETINOGRAPHY; METABOLISM; METHODOLOGY; MOUSE MUTANT; NICK END LABELING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AGE FACTORS; ANIMALS; ANISOTROPY; AXONS; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTRORETINOGRAPHY; EVOKED POTENTIALS, VISUAL; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; IN SITU NICK-END LABELING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROFIBROMATOSIS 1; OPTIC NERVE; OPTIC NERVE GLIOMA; PHOSPHOPYRUVATE HYDRATASE;

EID: 70149086254     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3181a3240b     Document Type: Article

References (43)

1. Friedman JM, Gutmann DH, MacCollin M, Riccardi VM, eds. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. 3rd ed. Baltimore, MA: Johns Hopkins University Press, 1999
2. Riccardi VM. Neurofibromatosis: Past, present, and future. N Engl J Med 1991;324:1283-1285
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, eds. WHO Classification of Tumours of the Central Nervous System. Geneva: WHO Press, 2007
4. Listernick R, Charrow J, Greenwald MJ, et al. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989;114:788-792
5. Habiby R, Silverman B, Listernick R, et al. Precocious puberty in children with neurofibromatosis type 1. J Pediatr 1995;126:364-367
6. Listernick R, Ferner RE, Liu GT, et al. Optic pathway gliomas in neurofibromatosis-1: Controversies and recommendations. Ann Neurol 2007;61:189-198
7. Janss A, Hiehle JF Jr, Yachnis AT. Neurofibromatosis type 1. Med Pediatr Oncol 1995;25:213-222
8. Listernick R, Charrow J, Greenwald M, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study. J Pediatr 1994;125:63-66
9. Wolsey DH, Larson SA, Creel D, et al. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? J AAPOS 2006;10:307-311
10. Trisciuzzi MT, Riccardi R, Piccardi M, et al. A fast visual evoked potential method for functional assessment and follow-up of childhood optic gliomas. Clin Neurophysiol 2004;115:217-226
11. Rodriguez FJ, Perry A, Gutmann DH, et al. Gliomas in neurofibromatosis type 1: A clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 2008;67:240-249
12. Kornreich L, Blaser S, Schwarz M, et al. Optic pathway glioma: Correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol 2001;22:1963-1969
13. Hamstra DA, Rehemtulla A, Ross BD. Diffusion magnetic resonance imaging: A biomarker for treatment response in oncology. J Clin Oncol 2007;25:4104-4109 (Pubitemid 47495868)
14. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000;92:2029-2036
15. Moffat BA, Chenevert TL, Lawrence TS, et al. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005;102: 5524-5529
16. Dalla Via P, Opocher E, Pinello ML, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro-oncol 2007;9: 430-437
17. Bajenaru ML, Hernandez MR, Perry A, et al. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res 2003;63:8573-8577
18. Zhu Y, Romero MI, Ghosh P, et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 2001;15:859-876
19. Bajenaru ML, Zhu Y, Hedrick NM, et al. Astrocyte-specific inactivation of the neurofibromatosis 1 gene (NF1) is insufficient for astrocytoma formation. Mol Cell Biol 2002;22:5100-5113
20. Srinivas S, Watanabe T, Lin CS, et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 2001;1:4
21. Ridder WH 3rd, Nusinowitz S. The visual evoked potential in the mouse-origins and response characteristics. Vision Res 2006;46:902-913
22. Brantley MA Jr, Jain S, Barr EE, et al. Neurturin-mediated ret activation is required for retinal function. J Neurosci 2008;28:4123-4135
23. Pierpaoli C, Basser PJ. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893-906
24. Hegedus B, Dasgupta B, Shin JE, et al. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell 2007;1: 443-457
25. Falsini B, Ziccardi L, Lazzareschi I, et al. Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings. J Neurooncol 2008; 88:87-96
26. Bajenaru ML, Garbow JR, Perry A, et al. Natural history of neurofibromatosis 1Yassociated optic nerve glioma in mice. Ann Neurol 2005; 57:119-127
27. Fraser MM, Zhu X, Kwon CH, et al. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res 2004;64: 7773-7779
28. Zhu Y, Harada T, Liu L, et al. Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation. Development 2005;132:5577-5588
29. Raymond ID, Vila A, Huynh UC, et al. Cyan fluorescent protein expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina. Mol Vis 2008;14:1559-1574
30. Jeon CJ, Strettoi E, Masland RH. The major cell populations of the mouse retina. J Neurosci 1998;18:8936-8946
31. Dasgupta B, Yi Y, Chen DY, et al. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1Yassociated human and mouse brain tumors. Cancer Res 2005;65:2755-2760
32. Hegedus B, Banerjee D, Yeh TH, et al. Preclinical cancer therapy in a mouse model of neurofibromatosis-1 optic glioma. Cancer Res 2008;68: 1520-1528
33. Daginakatte GC, Gutmann DH. Neurofibromatosis-1 (Nf1) heterozygous brain microglia elaborate paracrine factors that promote Nf1-deficient astrocyte and glioma growth. Hum Mol Genet 2007;16:1098-1112
34. Zhu Y, Ghosh P, Charnay P, et al. Neurofibromas in NF1: Schwann cell origin and role of tumor environment. Science 2002;296:920-922
35. Yang FC, Ingram DA, Chen S, et al. Nf1-dependent tumors require a microenvironment containing Nf1+/j and c-kitYdependent bone marrow. Cell 2008;135:437-448
36. Prusky GT, Alam NM, Beekman S, et al. Rapid quantification of adult and developing mouse spatial vision using a virtual optomotor system. Invest Ophthalmol Vis Sci 2004;45:4611-4616
37. Song SK, Yoshino J, Le TQ, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005;26: 132-140
38. Sun SW, Liang HF, Le TQ, et al. Differential sensitivity of in vivo and ex vivo diffusion tensor imaging to evolving optic nerve injury in mice with retinal ischemia. Neuroimage 2006;32:1195-1204
39. Warrington NM, Woerner BM, Daginakatte GC, et al. Spatiotemporal differences in cxcl12 expression and cyclic amp underlie the unique pattern of optic glioma growth in neurofibromatosis type 1. Cancer Res 2007;67:8588-8595
40. Kitano S, Morgan J, Caprioli J. Hypoxic and excitotoxic damage to cultured rat retinal ganglion cells. Exp Eye Res 1996;63:105-112
41. de Melo Reis RA, Cabral-da-Silva MC, et al. Muller glia factors induce survival and neuritogenesis of peripheral and central neurons. Brain Res 2008;1205:1-11
42. Baehr M, Bunge RP. Growth of adult rat retinal ganglion cell neurites on astrocytes. Glia 1990;3:293-300
43. McCaffery CA, Raju TR, Bennett MR. Effects of cultured astroglia on the survival of neonatal rat retinal ganglion cells in vitro. Dev Biol 1984; 104:441-48